Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (48)

Search Parameters:
Authors = Francesco Porta

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
18 pages, 770 KiB  
Article
Evaluation of Nailfold Capillaroscopy as a Novel Tool in the Assessment of Eosinophilic Granulomatosis with Polyangiitis
by Gianluca Screm, Ilaria Gandin, Lucrezia Mondini, Rossella Cifaldi, Paola Confalonieri, Chiara Bozzi, Francesco Salton, Giulia Bandini, Giorgio Monteleone, Michael Hughes, Paolo Cameli, Marileda Novello, Rossana Della Porta, Geri Pietro, Marco Confalonieri and Barbara Ruaro
J. Clin. Med. 2025, 14(15), 5311; https://doi.org/10.3390/jcm14155311 - 28 Jul 2025
Viewed by 227
Abstract
Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA), represent a spectrum of systemic disorders characterized by necrotizing inflammation of small- to medium-sized vessels. Nailfold videocapillaroscopy (NVC) is a validated, non-invasive [...] Read more.
Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA), represent a spectrum of systemic disorders characterized by necrotizing inflammation of small- to medium-sized vessels. Nailfold videocapillaroscopy (NVC) is a validated, non-invasive technique routinely employed in the assessment of microvascular involvement in systemic sclerosis and in the differential diagnosis of Raynaud’s phenomenon; its application in the context of AAV, particularly EGPA, has not been investigated yet. The present study aims to assess the presence and the possible pattern of microcirculatory abnormalities detected by NVC in EGPA patients, and to explore potential correlations between capillaroscopic findings and disease activity status. Methods: A total of 29 patients with EGPA (19 women and 10 men), aged between 51 and 73 years, and 29 age- and sex-matched healthy controls were retrospectively enrolled between October 2023 and April 2025, after providing informed consent and meeting the inclusion and exclusion criteria. NVC was conducted in both groups to assess various morphological parameters, and mean capillary density was also calculated. Results: This study observed the presence of capillaroscopic alterations in the EGPA group, including decreased capillary density (38%), neoangiogenesis (72%), rolling (100%), pericapillary stippling (66%), and inverted capillary apex (52%). Overall, when comparing healthy controls with EGPA patients, microcirculatory abnormalities were significantly more prevalent in the latter. Specifically, scores for neoangiogenesis, capillary rolling, pericapillary stippling, and inverted capillary apex showed p-values < 0.001. Conclusions: Our study demonstrates a higher prevalence of four nailfold videocapillaroscopic abnormalities in patients with EGPA compared to healthy controls. However, the identification of these capillaroscopic alterations as specific to EGPA requires further confirmation. Ongoing studies aim to explore the potential role of NVC as a diagnostic marker and to investigate its correlation with the clinical manifestations of EGPA. Full article
(This article belongs to the Special Issue Clinical Advances in Autoimmune Disorders)
Show Figures

Figure 1

18 pages, 4138 KiB  
Review
Fibromyalgia in the Era of Brain PET/CT Imaging
by Elisabetta Abenavoli, Valentina Berti, Matilde Nerattini, Piercarlo Sarzi-Puttini, Georgios Filippou, Alessandro Lucia, Gilberto Pari, Stefano Pallanti, Fausto Salaffi, Marina Carotti, Silvia Sirotti and Francesco Porta
J. Clin. Med. 2025, 14(12), 4166; https://doi.org/10.3390/jcm14124166 - 12 Jun 2025
Viewed by 1101
Abstract
Fibromyalgia syndrome (FMS) is a complex, heterogeneous disorder characterized by chronic widespread pain, fatigue, and cognitive disturbances. The multifactorial nature of FMS, with the involvement of central and peripheral mechanisms, hampers diagnosis and effective treatment. In recent years, positron emission tomography (PET) imaging [...] Read more.
Fibromyalgia syndrome (FMS) is a complex, heterogeneous disorder characterized by chronic widespread pain, fatigue, and cognitive disturbances. The multifactorial nature of FMS, with the involvement of central and peripheral mechanisms, hampers diagnosis and effective treatment. In recent years, positron emission tomography (PET) imaging has emerged as a valuable tool for exploring the neurobiological underpinnings of FMS. Several studies have investigated alterations in glucose metabolism, neurotransmitter systems (including opioid, dopamine, and GABAergic pathways), and neuroinflammation using various PET tracers. These findings have revealed distinct brain metabolic and molecular patterns in FMS patients compared to healthy controls, particularly in pain-related regions such as the thalamus, insula, and anterior cingulate cortex (ACC). Moreover, preliminary data suggest that PET imaging may help identify FMS subgroups with different pathophysiological profiles, potentially allowing for tailored therapeutic approaches. This review summarizes the current evidence on PET applications in FMS and discusses the potential role of molecular imaging in improving patient stratification and predicting treatment response. Full article
(This article belongs to the Special Issue Imaging in Diagnosis and Treatment of Musculoskeletal Disorders)
Show Figures

Figure 1

17 pages, 2275 KiB  
Article
Comparative Assessment of an IMU-Based Wearable Device and a Marker-Based Optoelectronic System in Trunk Motion Analysis: A Cross-Sectional Investigation
by Fulvio Dal Farra, Serena Cerfoglio, Micaela Porta, Massimiliano Pau, Manuela Galli, Nicola Francesco Lopomo and Veronica Cimolin
Appl. Sci. 2025, 15(11), 5931; https://doi.org/10.3390/app15115931 - 24 May 2025
Viewed by 2914
Abstract
Wearable inertial measurement units (IMUs) are increasingly used in human motion analysis due to their ability to measure movement in real-world environments. However, with rapid technological advancement and a wide variety of models available, it is essential to evaluate their performance and suitability [...] Read more.
Wearable inertial measurement units (IMUs) are increasingly used in human motion analysis due to their ability to measure movement in real-world environments. However, with rapid technological advancement and a wide variety of models available, it is essential to evaluate their performance and suitability for analyzing specific body regions. This study aimed to assess the accuracy and precision of an IMU-based sensor in measuring trunk range of motion (ROM). Twenty-seven healthy adults (11 males, 16 females; mean age: 31.1 ± 11.0 years) participated. Each performed trunk movements—flexion, extension, lateral bending, and rotation—while angular data were recorded simultaneously using a single IMU and a marker-based optoelectronic motion capture (MoCap) system. Analyses included accuracy indices, Root Mean Square Error (RMSE), Pearson’s correlation coefficient (r), concordance correlation coefficient (CCC), and Bland–Altman limits of agreement. The IMU showed high accuracy in rotation (92.4%), with strong correlation (r = 0.944, p < 0.001) and excellent agreement [CCC = 0.927; (0.977–0.957)]. Flexion (72.1%), extension (64.1%), and lateral bending (61.4%) showed moderate accuracy and correlations (r = 0.703, 0.564, and 0.430, p < 0.05). The RMSE ranged from 1.09° (rotation) to 3.01° (flexion). While the IMU consistently underestimated ROM, its accuracy in rotation highlights its potential as a cost-effective MoCap alternative, warranting further study for broader clinical use. Full article
Show Figures

Figure 1

16 pages, 3631 KiB  
Article
Metal Ion Supplementation to Boost Melanin Production by Streptomyces nashvillensis
by Odile Francesca Restaino, Talayeh Kordjazi, Francesco Tancredi, Paola Manini, Fabiana Lanzillo, Francesca Raganati, Antonio Marzocchella, Raffaele Porta and Loredana Mariniello
Int. J. Mol. Sci. 2025, 26(1), 416; https://doi.org/10.3390/ijms26010416 - 6 Jan 2025
Cited by 2 | Viewed by 1178
Abstract
As Streptomycetes might produce melanin to survive in stressful environmental conditions, like under metal exposure, supplementing metal ions to the growth medium could be a wise strategy for boosting the production of the pigment. The aim of this study was to test, for [...] Read more.
As Streptomycetes might produce melanin to survive in stressful environmental conditions, like under metal exposure, supplementing metal ions to the growth medium could be a wise strategy for boosting the production of the pigment. The aim of this study was to test, for the first time, the possibility of boosting S. nashvillensis DSM40314 melanin biosynthesis by adding to the growth medium singularly or, at the same time, different concentrations (1.0, 1.5, and 2.0 g∙L−1) of CuSO4 or/and Fe2(SO4)3. A maximum melanin production of 4.0 ± 0.1 g·L−1 was obtained in shake flasks with a 2.0 g∙L−1 coupled addition of the two metals, while the extracellular tyrosinase activities ranged values between 5.4 and 11.6 ± 0.1 U·L−1. The pigments produced in different conditions were precipitated from the broth supernatants under acidic conditions, purified, and characterized by UV-VIS, FT-IR, and NMR analyses that determined structures like eumelanin pigments. Fermentation experiments in stirred tank reactors allowed to scale up the process in more controlled conditions, further boosting the pigment production up to 4.9 ± 0.1 g·L−1, with an increase of about 22.0% compared to the results obtained in shake flasks. Full article
(This article belongs to the Special Issue Melanin and Other Pigments: Function, Synthesis and Characterization)
Show Figures

Figure 1

16 pages, 1761 KiB  
Article
Emerging Signatures of Hematological Malignancies from Gene Expression and Transcription Factor-Gene Regulations
by Daniele Dall’Olio, Federico Magnani, Francesco Casadei, Tommaso Matteuzzi, Nico Curti, Alessandra Merlotti, Giorgia Simonetti, Matteo Giovanni Della Porta, Daniel Remondini, Martina Tarozzi and Gastone Castellani
Int. J. Mol. Sci. 2024, 25(24), 13588; https://doi.org/10.3390/ijms252413588 - 19 Dec 2024
Viewed by 959
Abstract
Hematological malignancies are a diverse group of cancers developing in the peripheral blood, the bone marrow or the lymphatic system. Due to their heterogeneity, the identification of novel and advanced molecular signatures is essential for enhancing their characterization and facilitate its translation to [...] Read more.
Hematological malignancies are a diverse group of cancers developing in the peripheral blood, the bone marrow or the lymphatic system. Due to their heterogeneity, the identification of novel and advanced molecular signatures is essential for enhancing their characterization and facilitate its translation to new pharmaceutical solutions and eventually to clinical applications. In this study, we collected publicly available microarray data for more than five thousand subjects, across thirteen hematological malignancies. Using PANDA to estimate gene regulatory networks (GRNs), we performed hierarchical clustering and network analysis to explore transcription factor (TF) interactions and their implications on biological pathways. Our findings reveal distinct clustering patterns among leukemias and lymphomas, with notable differences in gene and TF expression profiles. Gene Set Enrichment Analysis (GSEA) identified 57 significantly enriched KEGG pathways, highlighting both common and unique biological processes across HMs. We also identified potential drug targets within these pathways, emphasizing the role of TFs such as CEBPB and NFE2L1 in disease pathophysiology. Our comprehensive analysis enhances the understanding of the molecular landscape of HMs and suggests new avenues for targeted therapeutic strategies. These findings also motivate the adoption of regulatory networks, combined with modern biotechnological possibilities, for insightful pan-cancer exploratory studies. Full article
(This article belongs to the Special Issue Molecular Progression of Genome-Related Diseases)
Show Figures

Figure 1

31 pages, 6009 KiB  
Review
The Role of Therapeutic Endoscopic Ultrasound in Management of Malignant Double Obstruction (Biliary and Gastric Outlet): A Comprehensive Review with Clinical Scenarios
by Giuseppe Dell’Anna, Rubino Nunziata, Claudia Delogu, Petra Porta, Maria Vittoria Grassini, Jahnvi Dhar, Rukaia Barà, Sarah Bencardino, Jacopo Fanizza, Francesco Vito Mandarino, Ernesto Fasulo, Alberto Barchi, Francesco Azzolini, Guglielmo Albertini Petroni, Jayanta Samanta, Antonio Facciorusso, Armando Dell’Anna, Lorenzo Fuccio, Sara Massironi, Alberto Malesci, Vito Annese, Nico Pagano, Gianfranco Donatelli and Silvio Daneseadd Show full author list remove Hide full author list
J. Clin. Med. 2024, 13(24), 7731; https://doi.org/10.3390/jcm13247731 - 18 Dec 2024
Cited by 7 | Viewed by 2774
Abstract
Endoscopic ultrasound (EUS)-guided interventions have revolutionized the management of malignant biliary obstruction (MBO) and gastric outlet obstruction (GOO), providing minimally invasive alternatives with improved outcomes. These procedures have significantly reduced the need for high-risk surgical interventions or percutaneous alternatives and have provided effective [...] Read more.
Endoscopic ultrasound (EUS)-guided interventions have revolutionized the management of malignant biliary obstruction (MBO) and gastric outlet obstruction (GOO), providing minimally invasive alternatives with improved outcomes. These procedures have significantly reduced the need for high-risk surgical interventions or percutaneous alternatives and have provided effective palliative care for patients with advanced gastrointestinal and bilio-pancreatic malignancies. EUS-guided biliary drainage (EUS-BD) techniques, including hepaticogastrostomy (EUS-HGS), choledochoduodenostomy (EUS-CDS), and antegrade stenting (EUS-AS), offer high technical and clinical success rates, with a good safety profile particularly when Endoscopic Retrograde Cholangiopancreatography (ERCP) is not feasible. EUS-HGS, which allows biliary drainage by trans-gastric route, is primarily used for proximal stenosis or in case of surgically altered anatomy; EUS-CDS with Lumen-Apposing Metal Stent (LAMS) for distal MBO (dMBO), EUS-AS as an alternative of EUS-HGS in the bridge-to-surgery scenario or when retrograde access is not possible and EUS-guided gallbladder drainage (EUS-GBD) with LAMS in case of dMBO with cystic duct patent without dilation of common bile duct (CDB). EUS-guided gastroenterostomy (EUS-GE) has already established its role as an effective alternative to surgical GE and enteral self-expandable metal stent, providing relief from GOO with fewer complications and faster recovery times. However, we do not yet have strong evidence on how to combine the different EUS-guided drainage techniques with EUS-GE in the setting of double obstruction. This comprehensive review aims to synthesize growing evidence on this topic by randomized controlled trials, cohort studies, and case series not only to summarize the efficacy, safety, and technical aspects of these procedures but also to propose a treatment algorithm based essentially on the anatomy and stage of the neoplasm to guide clinical decision-making, incorporating the principles of personalized medicine. This review also highlights the transformative impact of EUS-guided interventions on the treatment landscape for MBO and GOO. These techniques offer safer and more effective options than traditional approaches, with the potential for widespread clinical adoption. Further research is needed to refine these procedures, expand their applications, and improve patient care and quality of life. Full article
Show Figures

Figure 1

19 pages, 3307 KiB  
Review
Bioimpedance Analysis in CKD and HF Patients: A Critical Review of Benefits, Limitations, and Future Directions
by Edoardo La Porta, Alessandro Faragli, Alexander Herrmann, Francesco Paolo Lo Muzio, Luca Estienne, Stefano Geniere Nigra, Antonio Bellasi, Giacomo Deferrari, Giovanni Ricevuti, Salvatore Di Somma and Alessio Alogna
J. Clin. Med. 2024, 13(21), 6502; https://doi.org/10.3390/jcm13216502 - 30 Oct 2024
Cited by 5 | Viewed by 3114
Abstract
Bioimpedance analysis (BIA) is a validated non-invasive technique already proven to be useful for the diagnosis, prognosis, and management of body fluids in subjects with heart failure (HF) and chronic kidney disease (CKD). Although BIA has been widely employed for research purposes, its [...] Read more.
Bioimpedance analysis (BIA) is a validated non-invasive technique already proven to be useful for the diagnosis, prognosis, and management of body fluids in subjects with heart failure (HF) and chronic kidney disease (CKD). Although BIA has been widely employed for research purposes, its clinical application is still not fully widespread. The aim of this review is to provide a comprehensive overview of the state of the art of BIA utilization by analyzing the clinical benefits, limitations, and potential future developments in this clinically unexplored field. Full article
(This article belongs to the Section Nephrology & Urology)
Show Figures

Figure 1

9 pages, 1274 KiB  
Article
Clinical Efficacy and Safety of Ultrasound-Guided Injection with Low-Molecular-Weight Peptides from Hydrolyzed Collagen in Patients with Partial Supraspinatus Tendon Tears: A Pilot Study
by Luca Latini, Francesco Porta, Vincenzo Maccarrone, Davide Zompa, Edoardo Cipolletta, Riccardo Mashadi Mirza, Emilio Filippucci and Florentin Ananu Vreju
Life 2024, 14(11), 1351; https://doi.org/10.3390/life14111351 - 22 Oct 2024
Cited by 2 | Viewed by 2165
Abstract
Background: This study evaluates the clinical efficacy and safety of two ultrasound (US)-guided injections of a 5 mg/1 mL low-molecular-weight peptide (LWP) solution derived from hydrolyzed bovine collagen in patients with supraspinatus partial tendon tears. Methods: A total of 21 patients with symptomatic [...] Read more.
Background: This study evaluates the clinical efficacy and safety of two ultrasound (US)-guided injections of a 5 mg/1 mL low-molecular-weight peptide (LWP) solution derived from hydrolyzed bovine collagen in patients with supraspinatus partial tendon tears. Methods: A total of 21 patients with symptomatic partial tears of the supraspinatus tendon, detected by US, were consecutively enrolled and received one injection at a baseline visit (T0) and one after two weeks (T1). The primary outcome measure was the visual analogue scale (VAS) for pain. Secondary outcomes were the shoulder pain and disability index (SPADI) total score and the safety of LWP injections. Patients were examined at baseline (T0), at a week 2 follow-up visit (T1), and at a week 12 follow-up visit (T2). Results: A statistically significant improvement was found for both VAS pain and SPADI total scores, between T0 and T2 visits. US-guided injections were well tolerated and, apart from one patient with a progression of a tendon tear, no adverse events were recorded. Conclusions: Intratendinous tear US-guided injection therapy with an LWP solution was found to be safe and effective in improving both pain and shoulder function at a 12-week follow-up visit. The present pilot study should be considered the first step justifying a larger confirmatory investigation. Full article
(This article belongs to the Special Issue Musculoskeletal Medicine in Rheumatic Diseases)
Show Figures

Figure A1

13 pages, 3771 KiB  
Article
Real-World Experience of Ceftobiprole for Community- and Hospital-Acquired Pneumonia from a Stewardship Perspective
by Silvia Corcione, Ilaria De Benedetto, Massimiliano Carlin, Emanuele Emilio Pivetta, Silvia Scabini, Cecilia Grosso, Nour Shbaklo, Massimo Porta, Enrico Lupia and Francesco Giuseppe De Rosa
Microorganisms 2024, 12(4), 725; https://doi.org/10.3390/microorganisms12040725 - 3 Apr 2024
Cited by 6 | Viewed by 2556
Abstract
Ceftobiprole is a fifth-generation cephalosporin approved by European and American regulatory agencies for the treatment of community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). Ceftobiprole administration is useful in severe CAP as well as HAP where the potential is to save other β-lactams including [...] Read more.
Ceftobiprole is a fifth-generation cephalosporin approved by European and American regulatory agencies for the treatment of community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). Ceftobiprole administration is useful in severe CAP as well as HAP where the potential is to save other β-lactams including carbapenems or linezolid/vancomycin in clinical practice. The aim of this study was to report the real-world evidence of ceftobiprole in patients with CAP and HAP in a single center. In this retrospective study, we included 159 patients with CAP or HAP: 105 (66%) had CAP and 54 (34%) had HAP. The median age was 70 years (IQR 60–77), the median Charlson Comorbidity Index was 5 (IQR 3–7.5) and baseline INCREMENT ESBL score was 8 (IQR 6–11). Ceftobiprole was mostly given as a combination treatment (77%) or as a carbapenem-sparing strategy (44%). There were no differences in mortality between shorter and longer duration of treatment (<7 days compared with ≥7 days (HR 1.02, C.I. 0.58–1.77, p = 0.93) or between first-line (HR 1.00, C.I. 0.46–2.17, p = 0.989) and second-line therapy. Ceftobiprole use in CAP or HAP in the real world is effective as a first- and second-line treatment as well as a carbapenem-sparing strategy. Further studies are needed to explore the full potential of ceftobiprole, including its real-world use in antimicrobial stewardship programs. Full article
(This article belongs to the Special Issue Advances in Antibiotic and Drug-Resistance Mechanisms, 2nd Edition)
Show Figures

Figure 1

21 pages, 6875 KiB  
Article
Transmembrane Protein TMEM230, Regulator of Glial Cell Vascular Mimicry and Endothelial Cell Angiogenesis in High-Grade Heterogeneous Infiltrating Gliomas and Glioblastoma
by Cinzia Cocola, Edoardo Abeni, Valentina Martino, Eleonora Piscitelli, Paride Pelucchi, Ettore Mosca, Alice Chiodi, Tasnim Mohamed, Mira Palizban, Giovanni Porta, Helga Palizban, Giovanni Nano, Francesco Acquati, Antonino Bruno, Burkhard Greve, Daniela Gerovska, Valerio Magnaghi, Daniela Mazzaccaro, Giovanni Bertalot, James Kehler, Cristiana Balbino, Marcos J. Arauzo-Bravo, Martin Götte, Ileana Zucchi and Rolland A. Reinboldadd Show full author list remove Hide full author list
Int. J. Mol. Sci. 2024, 25(7), 3967; https://doi.org/10.3390/ijms25073967 - 3 Apr 2024
Cited by 2 | Viewed by 2841
Abstract
High-grade gliomas (HGGs) and glioblastoma multiforme (GBM) are characterized by a heterogeneous and aggressive population of tissue-infiltrating cells that promote both destructive tissue remodeling and aberrant vascularization of the brain. The formation of defective and permeable blood vessels and microchannels and destructive tissue [...] Read more.
High-grade gliomas (HGGs) and glioblastoma multiforme (GBM) are characterized by a heterogeneous and aggressive population of tissue-infiltrating cells that promote both destructive tissue remodeling and aberrant vascularization of the brain. The formation of defective and permeable blood vessels and microchannels and destructive tissue remodeling prevent efficient vascular delivery of pharmacological agents to tumor cells and are the significant reason why therapeutic chemotherapy and immunotherapy intervention are primarily ineffective. Vessel-forming endothelial cells and microchannel-forming glial cells that recapitulate vascular mimicry have both infiltration and destructive remodeling tissue capacities. The transmembrane protein TMEM230 (C20orf30) is a master regulator of infiltration, sprouting of endothelial cells, and microchannel formation of glial and phagocytic cells. A high level of TMEM230 expression was identified in patients with HGG, GBM, and U87-MG cells. In this study, we identified candidate genes and molecular pathways that support that aberrantly elevated levels of TMEM230 play an important role in regulating genes associated with the initial stages of cell infiltration and blood vessel and microchannel (also referred to as tumor microtubule) formation in the progression from low-grade to high-grade gliomas. As TMEM230 regulates infiltration, vascularization, and tissue destruction capacities of diverse cell types in the brain, TMEM230 is a promising cancer target for heterogeneous HGG tumors. Full article
(This article belongs to the Special Issue Research Progress of Tumor Endothelial Cells)
Show Figures

Figure 1

10 pages, 548 KiB  
Review
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
by Gianluca Screm, Lucrezia Mondini, Paola Confalonieri, Francesco Salton, Liliana Trotta, Mariangela Barbieri, Marco Mari, Nicolò Reccardini, Rossana Della Porta, Metka Kodric, Giulia Bandini, Michael Hughes, Mattia Bellan, Selene Lerda, Marco Confalonieri and Barbara Ruaro
Diagnostics 2024, 14(3), 254; https://doi.org/10.3390/diagnostics14030254 - 24 Jan 2024
Cited by 4 | Viewed by 2953
Abstract
Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) includes granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA), all of which are characterised by inflammation of small–medium-sized vessels. Progressive understanding of these diseases has allowed researchers and clinicians to start [...] Read more.
Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) includes granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA), all of which are characterised by inflammation of small–medium-sized vessels. Progressive understanding of these diseases has allowed researchers and clinicians to start discussing nailfold video capillaroscopy (NVC) as a future tool for many applications in daily practice. Today, NVC plays a well-established and validated role in differentiating primary from secondary Raynaud’s phenomenon correlated with scleroderma. Nevertheless, there has not been sufficient attention paid to its real potential in the ANCA-associated vasculitis. In fact, the role of NVC in vasculitis has never been defined and studied in a multicentre and multinational study. In this review, we carried out a literature analysis to identify and synthesise the possible role of capillaroscopy for patients with ANCA-associated vasculitis. Methods: Critical research was performed in the electronic archive (PUBMED, UpToDate, Google Scholar, ResearchGate), supplemented with manual research. We searched in these databases for articles published until November 2023. The following search words were searched in the databases in all possible combinations: capillaroscopy, video capillaroscopy, nailfold-video capillaroscopy, ANCA-associated vasculitis, vasculitis, granulomatosis with polyangiitis, EGPA, and microscopic polyangiitis. Results: The search identified 102 unique search results. After the evaluation, eight articles were selected for further study. The literature reported that capillaroscopy investigations documented non-specific abnormalities in 70–80% of AAV patients. Several patients showed neoangiogenesis, capillary loss, microhaemorrhages, and bushy and enlarged capillaries as the most frequent findings. Furthermore, the difference between active phase and non-active phase in AAV patients was clearly discernible. The non-active phase showed similar rates of capillaroscopy alterations compared to the healthy subjects, but the active phase had higher rates in almost all common abnormalities instead. Conclusions: Microvascular nailfold changes, observed in patients affected by vasculitis, may correlate with the outcome of these patients. However, these non-specific abnormalities may help in the diagnosis of vasculitis. As such, new analysis analyses are necessary to confirm our results. Full article
(This article belongs to the Special Issue Recent Advances in the Diagnosis and Treatment of Vascular Diseases)
Show Figures

Figure 1

22 pages, 3329 KiB  
Review
OTX Genes in Adult Tissues
by Alessandro Terrinoni, Giovanni Micheloni, Vittoria Moretti, Sabrina Caporali, Sergio Bernardini, Marilena Minieri, Massimo Pieri, Cristina Giaroni, Francesco Acquati, Lucy Costantino, Fulvio Ferrara, Roberto Valli and Giovanni Porta
Int. J. Mol. Sci. 2023, 24(23), 16962; https://doi.org/10.3390/ijms242316962 - 30 Nov 2023
Cited by 3 | Viewed by 2277
Abstract
OTX homeobox genes have been extensively studied for their role in development, especially in neuroectoderm formation. Recently, their expression has also been reported in adult physiological and pathological tissues, including retina, mammary and pituitary glands, sinonasal mucosa, in several types of cancer, and [...] Read more.
OTX homeobox genes have been extensively studied for their role in development, especially in neuroectoderm formation. Recently, their expression has also been reported in adult physiological and pathological tissues, including retina, mammary and pituitary glands, sinonasal mucosa, in several types of cancer, and in response to inflammatory, ischemic, and hypoxic stimuli. Reactivation of OTX genes in adult tissues supports the notion of the evolutionary amplification of functions of genes by varying their temporal expression, with the selection of homeobox genes from the “toolbox” to drive or contribute to different processes at different stages of life. OTX involvement in pathologies points toward these genes as potential diagnostic and/or prognostic markers as well as possible therapeutic targets. Full article
(This article belongs to the Section Molecular Genetics and Genomics)
Show Figures

Figure 1

10 pages, 264 KiB  
Case Report
Donor Cell Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: A Case Report and Literature Review
by Giovanni Micheloni, Annalisa Frattini, Marta Donini, Stefano Dusi, Anna Leszl, Annamaria Di Meglio, Martina Pigazzi, Antonio Musio, Marco Zecca, Tommaso Mina, Marco Rabusin, Pamela Roccia, Paolo Bernasconi, Irene Dambruoso, Antonella Minelli, Giuseppe Montalbano, Francesco Acquati, Giovanni Porta, Roberto Valli and Francesco Pasquali
Genes 2023, 14(11), 2085; https://doi.org/10.3390/genes14112085 - 16 Nov 2023
Viewed by 2121
Abstract
The patient reported here underwent hematopoietic stem cell transplantation (HSCT) due to chronic granulomatous disease (CGD) caused by biallelic mutations of the NCF1 gene. Two years later, he developed AML, which was unexpected and was recognized via sex-mismatched chromosomes as deriving from the [...] Read more.
The patient reported here underwent hematopoietic stem cell transplantation (HSCT) due to chronic granulomatous disease (CGD) caused by biallelic mutations of the NCF1 gene. Two years later, he developed AML, which was unexpected and was recognized via sex-mismatched chromosomes as deriving from the donor cells; the patient was male, and the donor was his sister. Donor cell leukemia (DCL) is very rare, and it had never been reported in patients with CGD after HSCT. In the subsequent ten years, the AML relapsed three times and the patient underwent chemotherapy and three further HSCTs; donors were the same sister from the first HSCT, an unrelated donor, and his mother. The patient died during the third relapse. The DCL was characterized since onset by an acquired translocation between chromosomes 9 and 11, with a molecular rearrangement between the MLL and MLLT3 genes—a quite frequent cause of AML. In all of the relapses, the malignant clone had XX sex chromosomes and this rearrangement, thus indicating that it was always the original clone derived from the transplanted sister’s cells. It exhibited the ability to remain quiescent in the BM during repeated chemotherapy courses, remission periods and HSCT. The leukemic clone then acquired different additional anomalies during the ten years of follow-up, with cytogenetic results characterized both by anomalies frequent in AML and by different, non-recurrent changes. This type of cytogenetic course is uncommon in AML. Full article
(This article belongs to the Special Issue Genetic Basis of Leukemia)
24 pages, 7399 KiB  
Review
The Other Side of Plastics: Bioplastic-Based Nanoparticles for Drug Delivery Systems in the Brain
by Erwin Pavel Lamparelli, Marianna Marino, Marta Anna Szychlinska, Natalia Della Rocca, Maria Camilla Ciardulli, Pasqualina Scala, Raffaella D'Auria, Antonino Testa, Andrea Viggiano, Francesco Cappello, Rosaria Meccariello, Giovanna Della Porta and Antonietta Santoro
Pharmaceutics 2023, 15(11), 2549; https://doi.org/10.3390/pharmaceutics15112549 - 28 Oct 2023
Cited by 8 | Viewed by 3631
Abstract
Plastics have changed human lives, finding a broad range of applications from packaging to medical devices. However, plastics can degrade into microscopic forms known as micro- and nanoplastics, which have raised concerns about their accumulation in the environment but mainly about the potential [...] Read more.
Plastics have changed human lives, finding a broad range of applications from packaging to medical devices. However, plastics can degrade into microscopic forms known as micro- and nanoplastics, which have raised concerns about their accumulation in the environment but mainly about the potential risk to human health. Recently, biodegradable plastic materials have been introduced on the market. These polymers are biodegradable but also bioresorbable and, indeed, are fundamental tools for drug formulations, thanks to their transient ability to pass through biological barriers and concentrate in specific tissues. However, this “other side” of bioplastics raises concerns about their toxic potential, in the form of micro- and nanoparticles, due to easier and faster tissue accumulation, with unknown long-term biological effects. This review aims to provide an update on bioplastic-based particles by analyzing the advantages and drawbacks of their potential use as components of innovative formulations for brain diseases. However, a critical analysis of the literature indicates the need for further studies to assess the safety of bioplastic micro- and nanoparticles despite they appear as promising tools for several nanomedicine applications. Full article
(This article belongs to the Special Issue Nanocarriers for Drug Delivery in Tissue Engineering)
Show Figures

Figure 1

15 pages, 1561 KiB  
Review
Emerging Insights into Molecular Mechanisms of Inflammation in Myelodysplastic Syndromes
by Veronica Vallelonga, Francesco Gandolfi, Francesca Ficara, Matteo Giovanni Della Porta and Serena Ghisletti
Biomedicines 2023, 11(10), 2613; https://doi.org/10.3390/biomedicines11102613 - 23 Sep 2023
Cited by 8 | Viewed by 2798
Abstract
Inflammation impacts human hematopoiesis across physiologic and pathologic conditions, as signals derived from the bone marrow microenvironment, such as pro-inflammatory cytokines and chemokines, have been shown to alter hematopoietic stem cell (HSCs) homeostasis. Dysregulated inflammation can skew HSC fate-related decisions, leading to aberrant [...] Read more.
Inflammation impacts human hematopoiesis across physiologic and pathologic conditions, as signals derived from the bone marrow microenvironment, such as pro-inflammatory cytokines and chemokines, have been shown to alter hematopoietic stem cell (HSCs) homeostasis. Dysregulated inflammation can skew HSC fate-related decisions, leading to aberrant hematopoiesis and potentially contributing to the pathogenesis of hematological disorders such as myelodysplastic syndromes (MDS). Recently, emerging studies have used single-cell sequencing and muti-omic approaches to investigate HSC cellular heterogeneity and gene expression in normal hematopoiesis as well as in myeloid malignancies. This review summarizes recent reports mechanistically dissecting the role of inflammatory signaling and innate immune response activation due to MDS progression. Furthermore, we highlight the growing importance of using multi-omic techniques, such as single-cell profiling and deconvolution methods, to unravel MDSs’ heterogeneity. These approaches have provided valuable insights into the patterns of clonal evolution that drive MDS progression and have elucidated the impact of inflammation on the composition of the bone marrow immune microenvironment in MDS. Full article
(This article belongs to the Special Issue Pathophysiological Mechanisms of Leukocyte Activation and Recruitment)
Show Figures

Figure 1

Back to TopTop